ARCHIVES

Alternating Mammography, MRI Tested For High-Risk Women

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

South Carolina Clinic and Anil Potti Part Ways

February 24, 2012

In Brief: Recompetition Of Frederick Contract Flops, As Others Leave The Field To Litton-Bionetics

April 15, 1977

COMMIT Moving Into Implementation

July 15, 1988

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

Centers Recruting Patients With Mantle Cell Lymphoma

October 29, 2004